Page 156 – Clinical Laboratory int.

SPT Labtech integrates recent acquisitions into unified brand and portfolio

, 3 November 2021/in E-News /by panglobal

SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, has unveiled new branding that brings together its technologies with those from recent acquisitions into a single entity. The merged portfolio and positioning reflect SPT Labtech’s commitment to harnessing the ingenuity and product development track record […]

Sysmex Europe to relocate HQ to Hamburg

, 3 November 2021/in E-News /by panglobal

The Sysmex Group, international manufacturer and provider of innovative analytical instruments and services for laboratory diagnostics, is on a continuous course of growth and innovation. To accommodate this development, Sysmex Europe will relocate its headquarters for the EMEA region (Europe, Middle East and Africa) from Norderstedt to Hamburg.

Waters and Sartorius partner to help bioprocess scientists accelerate clone selection and process development

, 3 November 2021/in E-News /by panglobal

Waters Corporation and Sartorius will partner to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development. Sartorius and Waters will partner to implement the BioAccord LC-MS System from Waters as a new bioprocess analyser with data connectivity to Sartorius’ Ambr […]

BioPharma Dynamics unveil new cleanroom facility

, 2 November 2021/in E-News /by panglobal

BioPharma Dynamics, a leading life sciences solution provider, has opened a new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester. This expansion sees the company treble in size, with its new premises adding the capacity for product assembly and increased warehouse and office space.

Astellas, We are Pioneer Group launch Future Innovator Prize for pioneering biotechs

, 2 November 2021/in E-News /by panglobal

Astellas Venture Management, a wholly-owned venture capital subsidiary of Astellas Pharma, and We are Pioneer Group (WAPG), the UK’s largest ecosystem provider for science and innovation businesses, have set up a new collaborative sponsorship and first-of-its-kind initiative to support early stage science ventures.

Clinical toxicology screening: expanding the capability of highresolution mass spectrometry

, 2 November 2021/in Featured Articles /by 3wmedia

High-resolution mass spectrometry (MS) is a powerful analytical tool for clinical and forensic toxicology. It is capable of screening and confirming the presence of drugs and toxic compounds in various biological matrices. Using high-resolution MS/MS libraries helps to increase reporting confidence, verifies compound identification and reduces reporting of false-positive results.

Diagnosis of acute hepatic porphyria

, 2 November 2021/in Featured Articles /by panglobal

The acute porphyrias are a group of rare genetic metabolic disorders of the heme biosynthesis pathway, that result in the toxic accumulation of porphyrin precursors, notably porphobilinogen and delta-aminolevulinic acid. This article provides an overview of the biochemistry and the diagnosis of acute hepatic porphyria, which is crucial to managing this condition appropriately, preventing and […]

Insight into tumour marker development

, 2 November 2021/in Featured Articles /by panglobal

The growth of molecular genetic technologies has enabled advances in personalized medicine, particularly in the field of cancer diagnosis, prognosis and therapeutic decision-making. CLI caught up with Dr Jennifer Keynton (Diagnostics R&D Manager at Horizon Discovery) to find out more about the development of tumour markers and the role of reference standards in cancer diagnostics […]

Potential breakthrough in early diagnosis of HPV16 cancers

, 2 November 2021/in Featured Articles /by 3wmedia

The link between human papillomaviruses (HPVs) as the causal agents of anogenital warts and most incidences of cervical cancer has been longestablished, and it is in this background that the vaccine against HPV has been developed. However, more recently, HPV has also been found to be responsible for the increasing incidence and death from head, […]